There's an insurance name on Josh Brown's Best Stocks list that's been a homerun

The market is rewarding insurers with a rare combination of visible underwriting discipline and structural balance-sheet leverage. The key mechanism is not just better claims execution; it is that every basis point of expense-ratio improvement now compounds against a larger investable float, so the earnings uplift should persist even if premium growth moderates. That makes the leaders—especially the firms with scale, data, and capital-return capacity—look more like durable compounding machines than cyclicals.

Second-order winners are the large diversified carriers and the highest-quality capital allocators; second-order losers are smaller peers that cannot amortize technology spend across enough premium volume. If AI-enabled underwriting really lowers friction, the biggest moat is not the model itself but the proprietary claims/underwriting data loop, which should widen the gap between the top tier and everyone else over the next 6-18 months. Brokers and reinsurers could feel the pressure later if faster quoting and stronger carrier margins encourage more direct distribution and more aggressive capacity entering the market.

The near-term risk is that the move has become consensus-owned and valuation-sensitive after a sharp relative run. Over 1-3 months, the main falsifier is a disappointingly soft renewal season, reserve creep, or any sign that investment income peaking is enough to offset slowing underwriting momentum. Over 6-18 months, falling rates would be the bigger headwind because they directly reduce the reinvestment tailwind that is quietly doing a lot of the heavy lifting here.

Contrarian view: the street may be overrating the permanence of the AI-driven margin step-up. It is real, but it is also likely to diffuse quickly across the industry, so the absolute winners are the firms with scale, asset leverage, and the cleanest capital-return story, not necessarily the whole KIE complex.